Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Schizophrenia is a debilitating psychiatric disorder characterized by positive (hallucinations, delusions), negative (lack of motivation, flat affect), and cognitive (impaired memory and attention) symptoms. Aripiprazole, a dual-action antipsychotic, shows promise in enhancing brain structure and memory in schizophrenia, which may have downstream positive effects on negative symptoms and outcome. However, the mechanisms and timing underlying these potential effects have yet to be determined. This research aims to assess the effects of aripiprazole on brain structure, memory, negative symptoms, and functioning over a 15-month period following a first episode of psychosis. This work could identify both direct (positive, cognitive) and indirect (negative, outcome) effects of aripiprazole and highlight early treatment targets for schizophrenia. The partner organization will benefit from this project as they will be provided with scientific evidence on the potential benefits of their medication, particularly in areas that have traditionally not been targeted by pharmaceuticals. Identifying medications that target multiple symptoms of psychosis will benefit patients directly by promoting more comprehensive treatments and potentially better recovery and would benefit the larger community by reducing the burden on caregivers and the strain on the healthcare system.
Martin Lepage
Katie Lavigne
Otsuka Canada Pharmaceutical Inc
Psychology
Professional, scientific and technical services
McGill University
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.